| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evommune, Inc. (EVMN) has 14 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. EVMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.29M | $118.99M | - | |
| 10% | 5.29M | $118.99M | - | |
| 10% | 1.52M | $34.14M | - | |
| 10% | 294.5K | $6.63M | - | |
| CEO | 291.4K | $6.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Hopfner Robert Lorne | Director, 10% Owner | Buy | 1,000 | $17.35 | $17,350.00 | +33.0% | +29.1% | - | |
| Nov 7, 2025 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 1,250,000 | $16.00 | $20,000,000.00 | +56.6% | -9.5% | - | |
| Nov 7, 2025 | Lsp 7 Cooperative Ua | 10% Owner | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +46.4% | -9.5% | - | |
| Nov 7, 2025 | Verduyn-Van Weegen Felice Isabel | Director, 10% Owner | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +46.4% | -9.5% | - |